Mahenthiralingam E[au] - Search Results

Year	Number of Results
1989	1
1993	1
1994	1
1995	2
1996	2
1997	3
1998	3
1999	4
2000	4
2001	9
2002	8
2003	8
2004	8
2005	9
2006	5
2007	7
2008	8
2009	7
2010	6
2011	5
2012	1
2013	10
2014	5
2015	3
2016	1
2017	4
2018	3
2019	7
2020	10
2021	9
2022	6
2023	1

1

The life history of Lactobacillus acidophilus as a probiotic: a tale of revisionary taxonomy, misidentification and commercial success.

Bull M, Plummer S, Marchesi J, Mahenthiralingam E. Bull M, et al. Among authors: mahenthiralingam e. FEMS Microbiol Lett. 2013 Dec;349(2):77-87. doi: 10.1111/1574-6968.12293. Epub 2013 Oct 24. FEMS Microbiol Lett. 2013. PMID: 24152174

2

Understanding the challenges of non-food industrial product contamination.

Cunningham-Oakes E, Weiser R, Pointon T, Mahenthiralingam E. Cunningham-Oakes E, et al. Among authors: mahenthiralingam e. FEMS Microbiol Lett. 2019 Dec 1;366(23):fnaa010. doi: 10.1093/femsle/fnaa010. FEMS Microbiol Lett. 2019. PMID: 31977006 Free PMC article. Review.

3

Discovery, mode of action and secretion of Burkholderia sensu lato key antimicrobial specialised metabolites.

Petrova YD, Mahenthiralingam E. Petrova YD, et al. Among authors: mahenthiralingam e. Cell Surf. 2022 Oct 13;8:100081. doi: 10.1016/j.tcsw.2022.100081. eCollection 2022 Dec. Cell Surf. 2022. PMID: 36277081 Free PMC article. Review.

4

Emerging cystic fibrosis pathogens and the microbiome.

Mahenthiralingam E. Mahenthiralingam E. Paediatr Respir Rev. 2014 Jun;15 Suppl 1:13-5. doi: 10.1016/j.prrv.2014.04.006. Epub 2014 Apr 13. Paediatr Respir Rev. 2014. PMID: 24832700 Review.

5

Biotechnological potential within the genus Burkholderia.

O'Sullivan LA, Mahenthiralingam E. O'Sullivan LA, et al. Among authors: mahenthiralingam e. Lett Appl Microbiol. 2005;41(1):8-11. doi: 10.1111/j.1472-765X.2005.01758.x. Lett Appl Microbiol. 2005. PMID: 15960745 Free article. Review.

6

The multifarious, multireplicon Burkholderia cepacia complex.

Mahenthiralingam E, Urban TA, Goldberg JB. Mahenthiralingam E, et al. Nat Rev Microbiol. 2005 Feb;3(2):144-56. doi: 10.1038/nrmicro1085. Nat Rev Microbiol. 2005. PMID: 15643431 Review.

7

Burkholderia: an update on taxonomy and biotechnological potential as antibiotic producers.

Depoorter E, Bull MJ, Peeters C, Coenye T, Vandamme P, Mahenthiralingam E. Depoorter E, et al. Among authors: mahenthiralingam e. Appl Microbiol Biotechnol. 2016 Jun;100(12):5215-29. doi: 10.1007/s00253-016-7520-x. Epub 2016 Apr 26. Appl Microbiol Biotechnol. 2016. PMID: 27115756 Review.

8

Evaluating the alginate oligosaccharide (OligoG) as a therapy for Burkholderia cepacia complex cystic fibrosis lung infection.

Fischer R, Schwarz C, Weiser R, Mahenthiralingam E, Smerud K, Meland N, Flaten H, Rye PD. Fischer R, et al. Among authors: mahenthiralingam e. J Cyst Fibros. 2022 Sep;21(5):821-829. doi: 10.1016/j.jcf.2022.01.003. Epub 2022 Jan 24. J Cyst Fibros. 2022. PMID: 35086790 Clinical Trial.

9

The lung microbiota in children with cystic fibrosis captured by induced sputum sampling.

Weiser R, Oakley J, Ronchetti K, Tame JD, Hoehn S, Jurkowski TP, Mahenthiralingam E, Forton JT. Weiser R, et al. Among authors: mahenthiralingam e. J Cyst Fibros. 2022 Nov;21(6):1006-1012. doi: 10.1016/j.jcf.2022.01.006. Epub 2022 Jan 22. J Cyst Fibros. 2022. PMID: 35078737 Free article.

10

Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.

Mahenthiralingam E, Baldwin A, Dowson CG. Mahenthiralingam E, et al. J Appl Microbiol. 2008 Jun;104(6):1539-51. doi: 10.1111/j.1365-2672.2007.03706.x. Epub 2008 Jan 24. J Appl Microbiol. 2008. PMID: 18217926 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results